M&A Deal Summary |
|
---|---|
Date | 2019-12-19 |
Target | Health in Code |
Sector | Life Science |
Buyer(s) | Alantra Private Equity |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1986 |
PE ASSETS | 800M EUR |
Size | Middle-Market |
Type | Sector Agnostic |
Alantra Private Equity is a private equity firm focused on mid-sized buyout investments in Spain and Portugal. Thematic Investment approach focused in 4 sectors Food & Nutrition, Health & Wellness, Industry and TMT. Alantra Private Equity was formed in 1986 and is based in Madrid.
DEAL STATS | # |
---|---|
Overall | 88 of 89 |
Sector (Life Science) | 2 of 2 |
Type (Buyout (LBO, MBO, MBI)) | 72 of 72 |
Country (Spain) | 76 of 77 |
Year (2019) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-12-19 |
Genycell Biotech Esapna S.L.
Granada, Spain Genycell Biotech Esapna S.L. provides services for research laboratories specialized in human genetic diagnosis and is based in Granada, Spain. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-10-27 |
AG olives
Moron de la Frontera, Spain AG olives is a producer of olives that have brought together the best of tradition with the most contemporary production, packaging, and distribution processes, placing the company at the forefront of the andalusian agri-food sector and in the lead in the areas of vertical integration, sustainability, and global innovation. AG olives was founded in 1962 and is based in Moron de la Frontera, Spain. |
Buy | - |